WHO ICTRP trial
Microbiome & Psoriasis Study
EUCTR2018-001371-20-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-001371-20-FR |
|---|---|
| Public title | Microbiome & Psoriasis Study |
| Scientific title | Study of the role of local treatments on the modulation of the microbiome in psoriatic skin - Microbiome & Psoriasis Study |
| Primary sponsor | CHU de Nice |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | France |
| Conditions | Psoriasis MedDRA version: 20.0 Level: LLT Classification code 10050576 Term: Psoriasis vulgaris System Organ Class: 100000004858 ;Therapeutic area: Body processes [G] - Cell Physiological Phenomena [G04] |
| Interventions | Trade Name: ENSTILAR Product Name: ENSTILAR Pharmaceutical Form: Cutaneous foam Pharmaceutical form of the placebo: Cutaneous foam Route of administration of the placebo: Cutaneous use Trade Name: DERMOVAL Product Name: DERMOVAL… |
| Registration date | Nov 4, 2018 |
| Target size | 30 |
| Secondary IDs | 18-PP-03 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: